🇺🇸 FDA
Pipeline program

NT219

TYR-219-01

Phase 2 small_molecule completed

Quick answer

NT219 for Solid Tumor, Adult is a Phase 2 program (small_molecule) at PURPLE BIOTECH LTD. with 1 ClinicalTrials.gov record(s).

Program details

Company
PURPLE BIOTECH LTD.
Indication
Solid Tumor, Adult
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials